Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

Clinical trial NCT00376623 · COMPLETED

Trial details

NCT number: NCT00376623
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2006-07-25
Primary completion: 2008-04-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.